Center for Drug Evaluation and Research - PDFSEARCH.IO - Document Search Engine

Center for Drug Evaluation and Research
Results: 4314

#	Item
1	CENTER FOR DRUG EVALUATION AND RESEARCH DRUG SAFETY PRIORITIES 2017 Add to Reading List Source URL: www.fda.gov Language: English
2	CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 208573Orig1s000 SUMMARY REVIEW Add to Reading List Source URL: assets.documentcloud.org - Date: 2016-10-23 14:14:25
3	CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 022526Orig1s000 SUMMARY REVIEW Add to Reading List Source URL: www.accessdata.fda.gov - Date: 2015-10-09 07:18:21
4	MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH Add to Reading List Source URL: www.fda.gov - Date: 2007-11-23 08:41:11
5	Abstract # 2639 Enhanced (Q)SAR Models for Prediction Rodent Carcinogenicity Naomi L. Kruhlak1, Dongyu Guo1, Kevin P. Cross2, Lidiya Stavitskaya1 FDA Center for Drug Evaluation and Research (CDER), 10903 New Hampshire A Add to Reading List Source URL: www.leadscope.com - Date: 2015-11-13 06:28:16
6	Development of Improved QSAR Models for Predicting A-T Base Pair Mutations Lidiya Stavitskaya, Barbara L. Minnier, R. Daniel Benz, and Naomi L. Kruhlak FDA Center for Drug Evaluation and Research (CDER), 10903 New Hampsh Add to Reading List Source URL: www.leadscope.com Language: English - Date: 2016-01-15 17:48:32 Bacteria Gram-negative bacteria Cheminformatics Medicinal chemistry Computational chemistry Drug discovery Quantitative structureactivity relationship Salmonella Escherichia coli Mutagen UvrABC endonuclease
7	Microsoft Worddoc Add to Reading List Source URL: www.fda.gov Language: English Food and Drug Administration Health Medical research Pharmaceutical industry Drug safety Clinical research Investigational New Drug Treatment IND Center for Drug Evaluation and Research Drug development Expanded access New drug application
8	Abstract # 2640 Importance of Comprehensive Reporting of (Q)SAR Assessments Under ICH M7 Lidiya Stavitskaya, Barbara L. Minnier, Mark W. Powley, Neil R. Hartman, and Naomi L. Kruhlak FDA Center for Drug Evaluation and R Add to Reading List Source URL: www.leadscope.com Language: English - Date: 2016-01-15 17:48:32 Chemistry Academia Biology Cheminformatics Computational chemistry Drug discovery Medicinal chemistry Quantitative structureactivity relationship Ames test Mutagen IPCC Second Assessment Report Research
9	Development of Improved Salmonella Mutagenicity QSAR Models Using Structural Fingerprints of Known Toxicophores Lidiya Stavitskaya, Barbara L. Minnier, R. Daniel Benz, Naomi L. Kruhlak FDA Center for Drug Evaluation and Add to Reading List Source URL: www.leadscope.com Language: English - Date: 2016-01-15 17:48:32 Chemistry Machine learning Medical research Bacteria Cheminformatics Medicinal chemistry Computational chemistry Drug discovery Quantitative structureactivity relationship Cross-validation Validation Test set
10	ATTORNEY LISTINGS FINANCE & TRANSACTIONAL LOCATION Jane Adams Add to Reading List Source URL: www.managingip.com Language: English - Date: 2015-09-23 06:23:30 Biotechnology Pharmaceutical industry Drugs Pharmacy Biopharmaceutical Biosimilar Small molecule Pharmaceutical drug Antibody Center for Drug Evaluation and Research Personalized medicine